Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Authors: Manish C. Choudhary, Kara W. Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain, Carlee Moser, Michael D. Hughes, Justin Ritz, Ruy M. Ribeiro, Ruian Ke, Joan A. Dragavon, Arzhang Cyrus Javan, Ajay Nirula, Paul Klekotka, Alexander L. Greninger, Courtney V. Fletcher, Eric S. Daar, David A. Wohl, Joseph J. Eron, Judith S. Currier, Urvi M. Parikh, Scott F. Sieg, Alan S. Perelson, Robert W. Coombs, Davey M. Smith, Jonathan Z. Li, , David Smith, Arzhang Cyrus Javan, Mark Giganti, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott Sieg, William Fischer, Teresa Evering, Rachel Bender Ignacio, Sandra Cardoso, Katya Corado, Prasanna Jagannathan, Nikolaus Jilg, Sandy Pillay, Cynthia Riviere, Upinder Singh, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi

Published: 2022-10-26

DOI: 10.1038/s41564-022-01254-1

Source: Full article


Abstract

No abstract found.